- Herd Health Pays Producer Program rebate form link below
- A healthier dry period means better milk. Period.
- For intramammary infusion into the dry cow
- Provides a great return on investment and reduces the risk of new infections
- "Parlor Pails" offer convenient, efficient mastitis treatment for the large dairy farm
Formulated with cephapirin benzathine and shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows, when caused by Streptococcus agalactiae and Staphylococcus aureus including penicillin-resistant strains.
TOMORROW has been an effective extended therapy treatment for more than 25 years, and studies have shown no change in the development of bacterial resistance.1,2
Formulated to provide broad-spectrum and long-acting therapy that dry cows need.
- Unique Opti-Sert® tip helps prevent pushing harmful surface bacteria into the teat canal
- Reduces the risk of new infections
- Allows antibiotic contact with teat-canal infections
- Provides the option of partial or full insertion with an exclusive, easy-to-use protective cap.
- A recent head-to-head study conducted on six dairy farms in four states shows less than 5 percent of all dry cow mastitis pathogens at dry-off were Gram-negative.1
- First-generation cephalosporins continue to maintain high effectiveness against Gram-positive organisms, and are more effective against those pathogens than third-generation cephalosporins.2,3
- Head-to-head study showed no difference in efficacy between the leading dry cow mastitis tubes.1
- Authors of the study concluded that "due to the lack of difference in efficacy, other factors should be used in the consideration of dry cow mastitis treatment, including prudent use of antibiotics, withhold times and value."1
- ToMORROW provides superior value.
Infuse a 10 ml syringe (300 mg cephapirin activity per syringe) once each quarter has been completely milked out. Effective against both gram-positive and gram-negative bacteria, especially Strept agalactiae and Staph aureus.
72 hour milk withholding; 42 day slaughter withdrawal. Not to be used within 30 days of calving.
Proper Infusion Technique
1 Arruda AG, Godden S, Rapnicki P, et al. Randomized non-inferiority clinical trial evaluating three commercial dry cow mastitis preparations: I. Quarter-level outcomes. J Dairy Sci 2013;96(7):4419–4435.
2 Prescott JF. Antimicrobial chemotherapy. In: Hirsh DC, Maclachlan NJ, Walker RL, eds. Veterinary microbiology. 2nd ed. Ames: Iowa State University Press, 2004;30.
3 Pol M, Ruegg PL. Relationship between antimicrobial drug usage and antimicrobial susceptibility of Gram-positive mastitis pathogens. J Dairy Sci 2007;90(1):262–273.
Rebate Form: Herd Health Pays Producer Program (through October 31, 2018)
We honor Boehringer Ingelheim Contract Pricing on this item. Please Log In to see your Boehringer Ingelheim Contract Pricing on file with us for your account. If your price does not reflect Boehringer Ingelheim Contract Pricing or if you have any questions, please contact us at email@example.com or 800-321-0235, so we can address it promptly. Your satisfaction is Priority #1!
You May Also Like